CagrilintideCGL2

Images are illustrative. Actual specifications are as selected and confirmed in writing.

GLP-1 & Metabolic Research

Cagrilintide

Weight management and appetite regulation

Cagrilintide specifications and reference prices. Select a specification to add it to your cart.

2mg/vial x 10vials
Reference priceTemporarily sold out

For laboratory research only. Not for human or veterinary use.

COA 检测报告 / Reports

Compare all specifications & reference prices
SKUSpecification / packReference price (USD)
CGL22mg/vial x 10vialsTemporarily sold out
CGL55mg/vial x 10vialsUS$200
CGL1010mg/vial x 10vialsUS$358.82

Temporarily sold-out specifications can still be added to an inquiry to ask about restocking. An inquiry is not an order or an agreed price.

RESEARCH FOCUS

Main Uses & FAQs

This page organizes directly related data on weight management and appetite regulation of Cagrilintide. First, look at the research questions and findings, then check the population or species, study formulations, and scope of interpretation.

Main TopicsWeight Management · Appetite Regulation
USAGE REFERENCE

Cagrilintide · Usage reference (for research purposes)

The following presents common research-context references for reconstitution, storage, dosage and cycles. The following presents common references in research settings. This page does not constitute advice for use in humans or animals.

🧪Reconstitution

Suggested Diluent
Bacteriostatic Water (containing 0.9% benzyl alcohol); some peptides may use sterile water or acetic acid to aid dissolution. See the individual product descriptions.
Diluent Volume
Slowly introduce the diluent along the vial wall until the lyophilized powder is covered. A common example is 5 mg reconstituted with 2 mL of bacteriostatic water, yielding approximately 2.5 mg/mL. Referenced reconstitution volumes are approximately 1–2.5 mL, with 2 mL commonly used. It is suggested to select and record a fixed volume based on the COA supplied with the purchase.
Handling Notes
Introduce the diluent slowly along the vial wall rather than directly onto the lyophilized powder. Leave it for 60–90 seconds to dissolve naturally; do not shake vigorously.

💾Storage

Unreconstituted Lyophilized Powder
Refrigerate at 2–8°C, protected from light; avoid repeated freeze–thaw cycles.
After Reconstitution
Refrigerate at 2–8°C; a common recommendation is touse within 28 days; do not freeze.
Transport
For short periods, use insulated packaging with ice packs; avoid high temperatures and direct light.

📏Dosage Reference (Research)

Purpose / SettingCommon Reference
Administration RouteSubcutaneous injection
FrequencyOften used in combination with semaglutide

🔁Cycle

Often combined with Semaglutide; record reconstitution and injection time according to mixed vial.

View the Complete Usage Guide Library →

Note: The above describes common research-context references, rather than clinical recommendations. Refer to the batch COA and research protocol. For research use only; not for human or animal use.

Research SummaryKey Findings

What research findings exist regarding Cagrilintide and weight management and appetite regulation?

Targeting cagrilintide by the Calcr/Prlh neuron mechanism that regulates energy balance. Other research reports indicate mechanisms supporting weight reduction via AMY1 and AMY3 receptors.[1] ↗ [2] ↗

Before ReadingStudy populations, species, formulations and delivery conditions each have a defined scope. Research on an ingredient does not establish that this site's product batches have been validated for efficacy in humans or veterinary use.
3 Main ReferencesSorted by First Publication Date ↓
Animal Study2026REF. 01

What neural mechanisms have energy balance studies revealed?

Research Findings

Localizing the Calcr/Prlh neuron mechanism that locates cagrilintide regulating energy balance.[1] ↗

Study Design

Rat administration and cross-species brainstem atlas

Scope & Limitations

Mechanistic studies, not new human efficacy trials.

View the Article Title and Full Citation+

A cross-species atlas of the dorsal vagal complex reveals neural mediators of the effects of cagrilintide on energy balance.

Ludwig MQ, Coester B, Gordian D, Hassan S, Tomlinson AJ, Toure MH, Christensen OP, Lommi G, Moltke-Prehn A, Brown JM, Belmont-Rausch DM, Bau S, Bodur C, Gowda A, Wu I, Kernodle S, Dong V, Ayensu-Mensah M, Sabatini PV, Shin JH, Kirigiti M, Egerod KL, Le Foll C, Lundh S, Gerstenberg MK, Lutz TA, Kievit P, Secher A, Raun K, Myers MG, Pers TH

Nature metabolism · Volume/Issue Year 2026
First published 2026-06-01 · PMID 42260119
DOI 10.1038/s42255-026-01539-3

Animal Study2025REF. 02

What is the connection between amyloid receptors and changes in body weight?

Research Findings

Supports the mechanism of weight reduction through AMY1 and AMY3 receptors.[2] ↗

Study Design

High-fat diet wild-type and RAMP1/3 knockout mice

Scope & Limitations

Mouse study; not human clinical effect.

View the Article Title and Full Citation+

Cagrilintide lowers bodyweight through brain amylin receptors 1 and 3.

Carvas AO, Leuthardt A, Kulka P, Lommi G, Hassan S, Coester B, Lundh S, Pers T, Secher A, Raun K, Lutz TA, Le Foll C

EBioMedicine · Volume/Issue Year 2025
First published 2025-07-03 · PMID 40609154
DOI 10.1016/j.ebiom.2025.105836

Human Study2021 · Historical basic researchREF. 03

What did the Cagrilintide monotherapy weight loss study show?

Research Findings

Weekly dosing group loses more weight on average than placebo.[3] ↗

Study Design

Phase II of human randomized, double-blind dose exploration; 706 people

Scope & Limitations

2021 clinical basic research, not a new 2026 trial.

View the Article Title and Full Citation+

Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial.

Lau DCW, Erichsen L, Francisco AM, Satylganova A, le Roux CW, McGowan B, Pedersen SD, Pietiläinen KH, Rubino D, Batterham RL

Lancet (London, England) · Volume, issue, year 2021
First published 2021-11-16 · PMID 34798060
DOI 10.1016/S0140-6736(21)01751-7

i

Currently, 3 original studies related to the theme of this page have been selected. The number of studies includes different designs, populations, or preparations, not commercial clinical efficacy ratings. This page is a usage-oriented positive data selection, not a systematic review or dosing recommendation. Historical studies, combination preparations, and special models are all separately indicated.

GO DEEPER

What Questions Do These Studies Address?

Compare study populations, findings and scope.

↗
QUESTIONS, ANSWERED

Cagrilintide · Frequently Asked Questions.

What research findings exist regarding Cagrilintide and weight management and appetite regulation?+

Targeting cagrilintide by the Calcr/Prlh neuron mechanism that regulates energy balance. Other research reports indicate mechanisms supporting weight reduction via AMY1 and AMY3 receptors.[1] ↗ [2] ↗

Can conclusions about Cagrilintide monotherapy be shared with CagriSema?+

No. Single-drug dose exploration trials can support Cagrilintide's own weight management research; when CagriSema is used with another component, the combination effect must be evaluated in separate combination trials.[3] ↗

Cagrilintide—these conclusions apply to which study populations?+

Drug administration in rats and cross-species brainstem mapping; High-fat diet wild-type and RAMP1/3 knockout mice; Human randomized, double-blind dose exploration phase II; 706 participants. Mechanistic studies, not newly added human efficacy trials.[1] ↗ [2] ↗ [3] ↗

VENTRO PEPTIDES & BIOTECH · RESEARCH PRODUCT RETAIL

Research peptides. Shop by product.

Compare specifications, reference prices and COA reports. Add products to your cart to request a quote.

Ventro Peptides & Biotech Logo
QUALITY DOCUMENTSCOA BY PRODUCTGLOBAL DELIVERYTECHNICAL SUPPORT

01 / CATALOG

Browse products

7 products Product names, specifications, and prices follow the current quotation
SemaglutideSM10COA

Images are illustrative. Actual specifications are as selected and confirmed in writing.

GLP-1 & Metabolic Research

Semaglutide

10mg/vial x 10vials

US$90.91
TirzepatideTR20COA

Images are illustrative. Actual specifications are as selected and confirmed in writing.

GLP-1 & Metabolic Research

Tirzepatide

20mg/vial x 10vials

US$160.61
RetatrutideRT10COA

Images are illustrative. Actual specifications are as selected and confirmed in writing.

GLP-1 & Metabolic Research

Retatrutide

10mg/vial x 10vials

US$109.09
BPC157BC10COA

Images are illustrative. Actual specifications are as selected and confirmed in writing.

Repair & Recovery Research

BPC157

10mg/vial x 10vials

US$133.33
MOTS-CMS20COA

Images are illustrative. Actual specifications are as selected and confirmed in writing.

Longevity & Mitochondrial Research

MOTS-C

20mg/vial x 10vials

US$257.58
LiraglutideLR10COA

Images are illustrative. Actual specifications are as selected and confirmed in writing.

GLP-1 & Metabolic Research

Liraglutide

10mg*10vials

US$164.71
IGF-lr3IG1COA

Images are illustrative. Actual specifications are as selected and confirmed in writing.

Growth Hormone & IGF-1

IGF-lr3

1mg/vial x 10vials

US$505.88

03 / ABOUT VENTRO

Reliable peptide supply, built for long-term partnerships.

Ventro supports research product retail purchases with clear pack specifications, available quality documents, and responsive international support.

  • High-purity peptides
  • Available COA reports
  • COA & quality documentation
  • Flexible small-quantity purchases
  • Reliable global fulfillment
  • Research product retail support

04 / QUALITY SYSTEM

Quality without compromise

Browse the available COA reports by product. Confirm documentation for your order with our team.

Controlled quality workflowRaw material to final release
Responsive global supportProduct matching and technical support

RESEARCH PRODUCT INQUIRY

Submit a product inquiry

Tell us the product, specification, and expected quantity. Our team will respond with pricing and available documents.

Use another email app

Opening an inquiry creates a draft, not a sent message. Review and press Send in Gmail, WhatsApp or your email app. Opening a channel passes the draft to the chosen provider. Privacy & cookies

Contact Ventro

Choose a channel to contact the Ventro team directly.

Use another email app

Opening an inquiry creates a draft, not a sent message. Review and press Send in Gmail, WhatsApp or your email app. Opening a channel passes the draft to the chosen provider. Privacy & cookies

WhatsApp